Kamlanoflast In Amyotrophic Lateral Sclerosis

NCT07396818 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

ALS (Amyotrophic Lateral Sclerosis)
ALS
Neuro-Degenerative Disease
Neuro-Degenerative Diseases
Motor Neuron Disease (MND)

Interventions

DRUG: Kamlanoflast
DRUG: Kamlanoflast

Sponsor

Inflammasome Therapeutics